Grifols (GIKLY) Return on Equity (2011 - 2021)
Grifols (GIKLY) reported Return on Equity of 0.0% for Q4 2021, down 71.08% quarter-over-quarter from 0.0% in Q4 2017.
Grifols (GIKLY) Return on Equity (2011 - 2021) Analysis & Trends
Grifols has reported Return on Equity for 8 years, with the latest figure at 0.0% in Q4 2021.
- For the quarter ending Q4 2021, Return on Equity changed N/A year-over-year to 0.0%; the trailing twelve-month figure through Dec 2021 stood at 0.0% (changed N/A YoY), and the FY2025 full-year result was 0.0%, up 7.0% from the prior year.
- Return on Equity for Q4 2021 stood at 0.0%, down from 0.0% in the prior quarter.
- The five-year high for Return on Equity was 0.0% in Q4 2017, with the low at 0.0% in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Gsk | 93,699,046.73 Bn | 93,699,041.77 Bn | 7.76 Bn | - |
| 2 | Eli Lilly | 1,012.06 Bn | 1,006.77 Bn | 16.22 Bn | 0.01% |
| 3 | Johnson & Johnson | 560.67 Bn | 538.62 Bn | 15.96 Bn | 0.00% |
| 4 | AbbVie | 402.20 Bn | 392.85 Bn | 10.78 Bn | -0.01% |
| 5 | Merck | 298.59 Bn | 292.94 Bn | 12.09 Bn | 0.00% |
| 6 | Amgen | 188.77 Bn | 176.74 Bn | 5.87 Bn | 0.01% |
| 7 | Gilead Sciences | 160.22 Bn | 152.49 Bn | 5.52 Bn | 0.00% |
| 8 | Pfizer | 148.19 Bn | 135.42 Bn | -1.21 Bn | 0.00% |
| 9 | Bristol Myers Squibb | 116.72 Bn | 106.26 Bn | 8.07 Bn | 0.00% |
| 10 | Grifols | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 0.00% |
| Dec 31, 2017 | 0.00% |
| Dec 31, 2016 | 0.00% |
| Sep 30, 2016 | 0.00% |
| Dec 31, 2015 | 0.00% |
| Mar 31, 2015 | 0.00% |
| Dec 31, 2014 | 0.00% |
| Dec 31, 2013 | 0.00% |
| Sep 30, 2013 | 0.00% |
| Jun 30, 2013 | 0.00% |
| Mar 31, 2013 | 0.00% |
| Dec 31, 2012 | 0.00% |
| Sep 30, 2012 | 0.00% |
| Jun 30, 2012 | 0.00% |
| Mar 31, 2012 | 0.00% |
| Dec 31, 2011 | 0.00% |
| Sep 30, 2011 | 0.00% |